Cargando…
Prevalence, Distribution and IgG Antibody Levels Associated with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Health-System and Community-Based Employees and Patients
BACKGROUND: Following the high morbidity and mortality due to Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infections in New Orleans, Louisiana, we sought to assess progress toward herd immunity. METHODS: Ochsner Health employees and patients who volunteered for Abbott SARS-CoV-2 imm...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Southern Society for Clinical Investigation. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485713/ https://www.ncbi.nlm.nih.gov/pubmed/34606754 http://dx.doi.org/10.1016/j.amjms.2021.09.006 |
_version_ | 1784577590783115264 |
---|---|
author | Kabagambe, Edmond K Velasco-Gonzalez, Cruz Henry, Marcia B. Fort, Dan Wu, Qingli Sossaman, Gregory Laborde, Yvens Price-Haywood, Eboni Roberts, W. Mark Seoane, Leonardo |
author_facet | Kabagambe, Edmond K Velasco-Gonzalez, Cruz Henry, Marcia B. Fort, Dan Wu, Qingli Sossaman, Gregory Laborde, Yvens Price-Haywood, Eboni Roberts, W. Mark Seoane, Leonardo |
author_sort | Kabagambe, Edmond K |
collection | PubMed |
description | BACKGROUND: Following the high morbidity and mortality due to Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infections in New Orleans, Louisiana, we sought to assess progress toward herd immunity. METHODS: Ochsner Health employees and patients who volunteered for Abbott SARS-CoV-2 immunoglobulin G (IgG) antibody test between March 1 and May 1, 2020 were included. We estimated IgG prevalence and used logistic regression to estimate odds ratios (OR) and 95% confidence intervals (CI) for variables associated with IgG test status. RESULTS: Of the 13,343 participants with IgG test results, 78.6% were women, 70.6% were non-Hispanic White, 21.1% non-Hispanic Black, 2.9% Hispanic Americans and 5.4% belonged to other races. Overall, 7.99% (95% CI: 7.53-8.45%) of the participants tested IgG positive. In age-, sex- and body mass index (BMI)-adjusted analyses, non-Hispanic Blacks were 2.7-times more likely to test positive than non-Hispanic Whites (OR=2.72; 95% CI: 2.33-3.19). Corresponding ORs (95% CIs) were 1.29 (0.84-1.99) for Hispanic Americans and 1.22 (0.85-1.75) for Other race/ethnicities. Compared to participants in administrative occupations, physician assistants (OR=7.14; 95% CI: 1.72-29.6) and therapists (OR=4.74; 95% CI: 1.49-15.03) were significantly more likely to have IgG antibodies while the association among nurses was not significant (OR=2.35; 95% CI: 0.96-5.77). Relative to 1.40, the test threshold for positivity, our measurements indicate a strong immune response (5.38±1.69), especially among those with a higher BMI. CONCLUSIONS: SARS-COV-2 IgG antibodies were prevalent only in 8% of the participants. IgG prevalence was highest among non-Hispanic Blacks and participants with higher BMI but was lower among older participants. |
format | Online Article Text |
id | pubmed-8485713 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Southern Society for Clinical Investigation. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84857132021-10-04 Prevalence, Distribution and IgG Antibody Levels Associated with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Health-System and Community-Based Employees and Patients Kabagambe, Edmond K Velasco-Gonzalez, Cruz Henry, Marcia B. Fort, Dan Wu, Qingli Sossaman, Gregory Laborde, Yvens Price-Haywood, Eboni Roberts, W. Mark Seoane, Leonardo Am J Med Sci Clinical Investigation BACKGROUND: Following the high morbidity and mortality due to Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infections in New Orleans, Louisiana, we sought to assess progress toward herd immunity. METHODS: Ochsner Health employees and patients who volunteered for Abbott SARS-CoV-2 immunoglobulin G (IgG) antibody test between March 1 and May 1, 2020 were included. We estimated IgG prevalence and used logistic regression to estimate odds ratios (OR) and 95% confidence intervals (CI) for variables associated with IgG test status. RESULTS: Of the 13,343 participants with IgG test results, 78.6% were women, 70.6% were non-Hispanic White, 21.1% non-Hispanic Black, 2.9% Hispanic Americans and 5.4% belonged to other races. Overall, 7.99% (95% CI: 7.53-8.45%) of the participants tested IgG positive. In age-, sex- and body mass index (BMI)-adjusted analyses, non-Hispanic Blacks were 2.7-times more likely to test positive than non-Hispanic Whites (OR=2.72; 95% CI: 2.33-3.19). Corresponding ORs (95% CIs) were 1.29 (0.84-1.99) for Hispanic Americans and 1.22 (0.85-1.75) for Other race/ethnicities. Compared to participants in administrative occupations, physician assistants (OR=7.14; 95% CI: 1.72-29.6) and therapists (OR=4.74; 95% CI: 1.49-15.03) were significantly more likely to have IgG antibodies while the association among nurses was not significant (OR=2.35; 95% CI: 0.96-5.77). Relative to 1.40, the test threshold for positivity, our measurements indicate a strong immune response (5.38±1.69), especially among those with a higher BMI. CONCLUSIONS: SARS-COV-2 IgG antibodies were prevalent only in 8% of the participants. IgG prevalence was highest among non-Hispanic Blacks and participants with higher BMI but was lower among older participants. Southern Society for Clinical Investigation. Published by Elsevier Inc. 2022-01 2021-10-01 /pmc/articles/PMC8485713/ /pubmed/34606754 http://dx.doi.org/10.1016/j.amjms.2021.09.006 Text en © 2021 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Clinical Investigation Kabagambe, Edmond K Velasco-Gonzalez, Cruz Henry, Marcia B. Fort, Dan Wu, Qingli Sossaman, Gregory Laborde, Yvens Price-Haywood, Eboni Roberts, W. Mark Seoane, Leonardo Prevalence, Distribution and IgG Antibody Levels Associated with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Health-System and Community-Based Employees and Patients |
title | Prevalence, Distribution and IgG Antibody Levels Associated with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Health-System and Community-Based Employees and Patients |
title_full | Prevalence, Distribution and IgG Antibody Levels Associated with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Health-System and Community-Based Employees and Patients |
title_fullStr | Prevalence, Distribution and IgG Antibody Levels Associated with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Health-System and Community-Based Employees and Patients |
title_full_unstemmed | Prevalence, Distribution and IgG Antibody Levels Associated with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Health-System and Community-Based Employees and Patients |
title_short | Prevalence, Distribution and IgG Antibody Levels Associated with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Health-System and Community-Based Employees and Patients |
title_sort | prevalence, distribution and igg antibody levels associated with severe acute respiratory syndrome coronavirus 2 (sars-cov-2) among health-system and community-based employees and patients |
topic | Clinical Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485713/ https://www.ncbi.nlm.nih.gov/pubmed/34606754 http://dx.doi.org/10.1016/j.amjms.2021.09.006 |
work_keys_str_mv | AT kabagambeedmondk prevalencedistributionandiggantibodylevelsassociatedwithsevereacuterespiratorysyndromecoronavirus2sarscov2amonghealthsystemandcommunitybasedemployeesandpatients AT velascogonzalezcruz prevalencedistributionandiggantibodylevelsassociatedwithsevereacuterespiratorysyndromecoronavirus2sarscov2amonghealthsystemandcommunitybasedemployeesandpatients AT henrymarciab prevalencedistributionandiggantibodylevelsassociatedwithsevereacuterespiratorysyndromecoronavirus2sarscov2amonghealthsystemandcommunitybasedemployeesandpatients AT fortdan prevalencedistributionandiggantibodylevelsassociatedwithsevereacuterespiratorysyndromecoronavirus2sarscov2amonghealthsystemandcommunitybasedemployeesandpatients AT wuqingli prevalencedistributionandiggantibodylevelsassociatedwithsevereacuterespiratorysyndromecoronavirus2sarscov2amonghealthsystemandcommunitybasedemployeesandpatients AT sossamangregory prevalencedistributionandiggantibodylevelsassociatedwithsevereacuterespiratorysyndromecoronavirus2sarscov2amonghealthsystemandcommunitybasedemployeesandpatients AT labordeyvens prevalencedistributionandiggantibodylevelsassociatedwithsevereacuterespiratorysyndromecoronavirus2sarscov2amonghealthsystemandcommunitybasedemployeesandpatients AT pricehaywoodeboni prevalencedistributionandiggantibodylevelsassociatedwithsevereacuterespiratorysyndromecoronavirus2sarscov2amonghealthsystemandcommunitybasedemployeesandpatients AT robertswmark prevalencedistributionandiggantibodylevelsassociatedwithsevereacuterespiratorysyndromecoronavirus2sarscov2amonghealthsystemandcommunitybasedemployeesandpatients AT seoaneleonardo prevalencedistributionandiggantibodylevelsassociatedwithsevereacuterespiratorysyndromecoronavirus2sarscov2amonghealthsystemandcommunitybasedemployeesandpatients |